ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Gainers
Here are the top 10 ASX 200 shares today
Growth Shares
These top ASX 200 growth shares could rise 20% to 45%
Best Shares
Top ASX shares to buy for FY25
Share Market News
Where to invest $10,000 in ASX 200 shares in July
Healthcare Shares
What's the outlook for ASX healthcare shares in FY25?
Best Shares
Top ASX shares to buy in July 2024
Share Gainers
Here are the top 10 ASX 200 shares today
Broker Notes
Should you pounce on ResMed shares at around $28?
Healthcare Shares
ResMed shares rebounding as investors rush to buy the dip
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Fallers
Why Cettire, Metcash, ResMed, and Star Entertainment shares are sinking today
Healthcare Shares
ResMed share price plunges 13% as weight-loss results reawaken worries
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
